Tate & Lyle PLC:企業のM&A・事業提携・投資動向

◆英語タイトル:Tate & Lyle PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1092
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Tate & Lyle PLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Tate & Lyle PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Tate & Lyle PLC since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Tate & Lyle PLC’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Tate & Lyle PLC. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Tate & Lyle PLC’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Tate & Lyle PLC and its subsidiaries since 2007.
- Information about key financial and legal advisors for Tate & Lyle PLC’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Tate & Lyle PLC’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
PARTNERSHIP 23
Partnership – Deal reports 23
DIVESTMENTS 33
Divestments – Overview 33
Divestments – Deal reports 34
APPENDIX 58
Contact Us 58
About MarketLine Financial Deals Database 58
Deal Definition and Methodology 60
About MarketLine 67

List of Tables
Table 1: Tate & Lyle PLC M&A volume and value trend (2014-YTD2018)
Table 2: Tate & Lyle PLC M&A activity by geography (2014-YTD2018)
Table 3: Tate & Lyle PLC divestments volume and value trend (2014-YTD2018)
Table 4: Tate & Lyle PLC divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Tate & Lyle PLC M&A volume and value trend (2014-YTD2018)
Figure 2: Tate & Lyle PLC M&A activity by geography (2014-YTD2018)
Figure 3: Tate & Lyle PLC divestments volume and value trend (2014-YTD2018)
Figure 4: Tate & Lyle PLC divestments by geography (2014-YTD2018)

★海外企業調査レポート[Tate & Lyle PLC:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RTL Group S.A. (00007453):企業の財務・戦略的SWOT分析
    RTL Group S.A. (00007453) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CS Energy Ltd:発電所・企業SWOT分析
    CS Energy Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Pakistan State Oil Co Ltd (PSO):企業の財務・戦略的SWOT分析
    Pakistan State Oil Co Ltd (PSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Corpak MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Corpak MedSystems Inc (Corpak), a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accesso …
  • ObsEva SA (OBSV):製薬・医療:M&Aディール及び事業提携情報
    Summary ObsEva SA (ObsEva) is a clinical-stage biopharmaceutical company that develops and commercializes drugs for women’s reproductive health and pregnancy. The company's product portfolio comprises pipeline products which is being developed to control preterm labor by reducing inflammation, decre …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務情報
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ANS Group Plc:企業の戦略的SWOT分析
    ANS Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • BioVentrix Inc-医療機器分野:企業M&A・提携分析
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company provides revivent myocardial anchoring systems that restore the size, volume and resulting function of the left ventricle for improving cardiac function in heart fa …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ei Group plc:企業の戦略・SWOT・財務分析
    Ei Group plc - Strategy, SWOT and Corporate Finance Report Summary Ei Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Sultan Center Food Products Co. KSC (SULTAN):企業の財務・戦略的SWOT分析
    Sultan Center Food Products Co. KSC (SULTAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • AMO Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary AMO Pharma Ltd (Amo Pharma) is a biopharmaceutical company that develops novel treatments for serious and debilitating diseases. The company provides pipeline product portfolio such as AMO-01, and AMO-02. Its AMO-01 is being developed for the treatment of autism and intellectual disabilities …
  • Jyoti Structures Ltd (JYOTISTRUC)-エネルギー分野:企業M&A・提携分析
    Summary Jyoti Structures Ltd (JSL) is a turnkey engineering, procurement, and construction (EPC) services provider that designs, tests, manufactures, sources, constructs, and supplies transmission lines, substations, and microwave towers. It designs HVDC and river crossing transmission towers, subst …
  • Brookfield Renewable Energy Partners LP (BEP.UN):電力:M&Aディール及び事業提携情報
    Summary Brookfield Renewable Energy Partners LP (Brookfield Renewable) formerly Brookfield Renewable Energy Partners, L.P. is a renewable power company. It is a wholly owned subsidiary of Brookfield Asset Management Inc. It owns, operates and develops renewable power generation facilities across Nor …
  • Vertex Pharmaceuticals Inc (VRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of novel drugs for the treatment of serious and life-threatening diseases. The company offers Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treat …
  • Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone i …
  • Polar Power Inc (POLA):企業の財務・戦略的SWOT分析
    Polar Power Inc (POLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Genmab AS (GEN):企業の財務・戦略的SWOT分析
    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆